| Original language | English |
|---|---|
| Pages (from-to) | 486-497 |
| Number of pages | 11 |
| Journal | British Journal of Dermatology |
| Volume | 153 |
| DOIs | |
| Publication status | Published - Sept 2005 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- biologics
- efalizumab
- etanercept
- guideline
- infliximab
- psoriasis
- PLAQUE-TYPE PSORIASIS
- FACTOR-ALPHA ANTAGONISTS
- RANDOMIZED-TRIAL
- INFLIXIMAB MONOTHERAPY
- CONSENSUS STATEMENT
- PUSTULAR PSORIASIS
- EFALIZUMAB THERAPY
- HEPATITIS-B
- ETANERCEPT
- ARTHRITIS
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS